Skip to content

CVE-2024-47608

Definetlynotai Logicytics vulnerability

9.8 CRITICALEPSS 0.66%
  1. Published1 Oct 2024

Description

Logicytics is designed to harvest and collect data for forensic analysis. Logicytics has a basic vuln affecting compromised devices from shell injections. This vulnerability is fixed in 2.3.2.

CVSS 3.1 breakdown

Attack vectorNetwork
Attack complexityLow
Privileges requiredNone
User interactionNone
ScopeUnchanged
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected products

Definetlynotai Logicytics≤ 2.3.1

Remediation

No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.

Frequently asked

Is CVE-2024-47608 being actively exploited?

CVE-2024-47608 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.66%.

How severe is CVE-2024-47608?

CVE-2024-47608 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 0.66% probability of exploitation.

Which products are affected by CVE-2024-47608?

Affected products include Definetlynotai Logicytics.

How do I fix CVE-2024-47608?

Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2024-47608 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

Get Patch this first every Monday

Five vulnerabilities that matter this week, ranked on real exploitation. Plain language, one email, no spam.

You can unsubscribe with one click from every issue. We handle your details as described in our privacy policy.

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.